Anthony Hunt is CEO at REPLIGEN CORP (RGEN). They have made 32 open-market trades across 1 company since 2016, most recently 2026-06-10.
CIK 0001606030
1 open-market purchase totalling $248K since 2024, against 31 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RGEN | 89,062 | $15.6M |
| BLFS | 15,046 | $581K |
| MASS | 44,168 | $497K |
| Total | $16.7M |
Shares reported on the most recent Form 4, priced at the 2026-06-12 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGEN | SELL | 2025-11-13 | 2025-11-14 | $154.78 | $5.5M | +12.4% | +5.4% | -12.9% |
| RGEN | SELL | 2025-11-12 | 2025-11-13 | $156.99 | $7.1M | +18.6% | +10.9% | -3.7% |
| RGEN | SELL | 2025-09-10 | 2025-09-11 | $120.52 | $7.0M | +4.6% | +25.5% | +38.3% |
| RGEN | SELL | 2025-05-15 | 2025-05-16 | $123.70 | $6.5M | -1.3% | +1.7% | +2.2% |
| RGEN | SELL | 2025-03-17 | 2025-03-19 | $152.52 | $8.1M | -9.5% | -6.4% | -14.0% |
| RGEN | SELL | 2024-11-21 | 2024-11-22 | $139.67 | $6.8M | -0.4% | +2.0% | +13.9% |
| RGEN | SELL | 2024-09-10 | 2024-09-12 | $145.37 | $6.5M | -0.1% | +0.0% | +8.6% |
| RGEN | BUY | 2024-06-14 | 2024-06-14 | $124.08 | $248K | -0.8% | -3.9% | +11.2% |
| RGEN | SELL | 2024-05-21 | 2024-05-22 | $168.07 | $6.1M | -10.7% | -24.3% | -9.2% |
| RGEN | SELL | 2024-03-08 | 2024-03-11 | $197.42 | $6.6M | +3.4% | -8.9% | -26.9% |
| RGEN | SELL | 2022-11-11 | 2022-11-14 | $200.00 | $5.0M | -16.8% | -13.9% | -8.7% |
| RGEN | SELL | 2022-09-08 | 2022-09-09 | $224.73 | $11.9M | -11.0% | -10.3% | -25.0% |
| RGEN | SELL | 2022-07-21 | 2022-07-22 | $200.00 | $5.0M | +20.3% | +12.9% | -14.5% |
| RGEN | SELL | 2021-11-18 | 2021-11-19 | $276.85 | $9.6M | -5.5% | -5.2% | -35.9% |
| RGEN | SELL | 2021-09-09 | 2021-09-13 | $294.75 | $14.7M | +11.7% | -12.8% | -10.8% |
| RGEN | SELL | 2021-05-19 | 2021-05-20 | $171.37 | $7.6M | -2.0% | +7.7% | +39.9% |
| RGEN | SELL | 2021-03-12 | 2021-03-12 | $190.29 | $3.4M | -3.4% | +5.7% | -3.0% |
| RGEN | SELL | 2021-03-04 | 2021-03-08 | $190.19 | $8.3M | +7.6% | +8.3% | -1.1% |
| RGEN | SELL | 2020-11-19 | 2020-11-23 | $185.59 | $6.0M | +1.3% | +5.9% | +13.3% |
| RGEN | SELL | 2020-09-10 | 2020-09-14 | $148.20 | $13.4M | -7.3% | +12.5% | +21.9% |
| RGEN | SELL | 2020-05-21 | 2020-05-26 | $139.76 | $13.1M | -9.4% | -13.7% | +10.0% |
| RGEN | SELL | 2020-03-03 | 2020-03-05 | $89.84 | $1.3M | +7.7% | +11.2% | +40.4% |
| RGEN | SELL | 2020-02-25 | 2020-02-27 | $90.41 | $2.8M | +15.8% | +15.8% | +54.7% |
| RGEN | SELL | 2019-09-19 | 2019-09-23 | $82.83 | $559K | -7.3% | -1.9% | +14.0% |
| RGEN | SELL | 2019-09-09 | 2019-09-11 | $82.27 | $1.9M | +1.4% | -3.2% | +14.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.